Merck turning to machine learning to prevent drug shortages

Merck plans to use a cloud-based software platform to better predict and prevent drug shortages, according to The Wall Street Journal.

The platform, developed by healthcare software company TraceLink, will analyze in real time data from pharmacies, hospitals and wholesale distributors. By using analytics and machine learning, the software can improve predictions and help drugmakers better match drug demand.

The software could also save drugmakers hundreds of millions of dollars annually by reducing waste and avoiding costs like expedited shipments, because it can track a drug's status at every step in the supply chain. The platform currently holds data on more than 6 billion drugs.

Merck plans to start testing the platform later this year, according to the WSJ. TraceLink is currently developing machine-learning algorithms to use in the pilot, which will start with immuno-oncology drugs.

Read the full article here.

More articles on pharmacy:
Novant Health to open health clinics inside Walgreens
GlaxoSmithKline recalls prescription heartburn drug globally
BIO CEO to step down at the end of 2020

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.